Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in Type 2 diabetic patients of Chinese Han origin

Journal of Endocrinological Investigation

Volumn 35, Issue 4, 2012, Pages 378-383

  Xu, Y ^a   Bao, Q ^a   He, B ^b   Pan, Y ^b   Zhang, R ^b   Mao, X ^b   Tang, Z ^b   Qu, L ^b   Zhu, C ^a   Tian, F ^a   Wang, S ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin I converting enzyme (ACE); Angiotensin I converting enzyme 2 (ACE2); Angiotensin II type 1 receptor (AT1R); Dyslipidemia; Polymorphism; Renin angiotensin system (RAS); Type 2 diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84863931834     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7797     Document Type: Article

References (40)

1. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275: 33238-43.
2. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277: 14838-43. (Pubitemid 34952556)
3. Miller JA, Scholey JW. The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 2004, 13: 101-6. (Pubitemid 39069905)
4. Henriksen EJ. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2007, 293: R974-80. (Pubitemid 47358914)
5. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab 2004, 30: 487-96. (Pubitemid 40070350)
6. Goldberg IJ. Clinical review 124: Diabetic dyslipidemia: Causes and consequences. J Clin Endocrinol Metab 2001, 86: 965-71. (Pubitemid 32322966)
7. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005, 36: 232-40. (Pubitemid 40755136)
8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin i-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86: 1343-6. (Pubitemid 20370444)
9. Thekkumkara TJ, Linas SL. Evidence for involvement of 3′-untranslated region in determining angiotensin ii receptor coupling specificity to g-protein. Biochem J 2003, 370: 631-9. (Pubitemid 36315151)
10. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin ii type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994, 24: 63-9. (Pubitemid 24195405)
11. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-ii type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344: 910-3. (Pubitemid 24295876)
12. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD, Wu MY. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type ii diabetes with end-stage renal disease in taiwan. J Chin Med Assoc 2003, 66: 51-6. (Pubitemid 37265500)
13. Mollsten A, Kockum I, Svensson M, et al. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complications 2008, 22: 377-83.
14. Zhong J, Yan Z, Liu D, et al. Association of angiotensin-converting enzyme 2 gene a/g polymorphism and elevated blood pressure in chinese patients with metabolic syndrome. J Lab Clin Med 2006, 147: 91-5. (Pubitemid 43189001)
15. World Health Organization. WHO Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization 1999.
16. Fang Y, Wang ZL, Ning TH, et al. Suggestions on prevention and treatment of dyslipidema. Chin J Cardiol 1997, 25: 169-75.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992, 20: 1433.
18. Feng Y, Niu T, Xu X, et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002, 51: 1986-8. (Pubitemid 34564315)
19. Hattori Y, Akimoto K, Gross SS, Hattori S, Kasai K. Angiotensin-iiinduced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 2005, 48: 1066-74. (Pubitemid 40909640)
20. Leung PS, Carlsson PO. Pancreatic islet renin angiotensin system: Its novel roles in islet function and in diabetes mellitus. Pancreas 2005, 30: 293-8. (Pubitemid 40586804)
21. Engeli S, Schling P, Gorzelniak K, et al. The adipose-tissue renin-angiotensin-aldosterone system: Role in the metabolic syndrome? Int J Biochem Cell Biol 2003, 35: 807-25. (Pubitemid 36379323)
22. Ambrosioni E, Bacchelli S, Degli Esposti D, Borghi C. ACE-inhibitors and atherosclerosis. Eur J Epidemiol 1992, 8 (Suppl 1): 129-33.
23. Daimon M, Oizumi T, Saitoh T, et al. The D allele of the angiotensin-converting enzyme insertion/ deletion (i/d) polymorphism is a risk factor for type 2 diabetes in a population-based japanese sample. Endocr J 2003, 50: 393-8. (Pubitemid 37129031)
24. Stephens JW, Dhamrait SS, Cooper JA, et al. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005, 84: 83-9. (Pubitemid 40082608)
25. Schmidt S, Ritz E. Angiotensin i converting enzyme gene polymorphism and diabetic nephropathy in type ii diabetes. Nephrol Dial Transplant 1997, 12 (Suppl 2): 37-41. (Pubitemid 27331303)
26. Grammer TB, Renner W, von Karger S, Boehm BO, Winkelmann BR, Maerz W. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol Genet Metab 2006, 88: 378-83. (Pubitemid 44107763)
27. Lee YJ, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002, 25: 1002-8. (Pubitemid 41110485)
28. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999, 17: 555-60. (Pubitemid 29308566)
29. Hennes MM, O'Shaughnessy IM, Kelly TM, LaBelle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 1996, 28: 120-6. (Pubitemid 26231100)
30. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 2001, 24: 356-61. (Pubitemid 32119138)
31. Muthumala A, Gable DR, Palmen J, et al. Is the influence of variation in the ACE gene on the prospective risk of Type 2 diabetes in middle-aged men modified by obesity? Clin Sci (Lond) 2007, 113: 467-72. (Pubitemid 350221389)
32. Mehri S, Koubaa N, Hammami S, et al. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population. Life Sci 2010, 87: 49-54.
33. Bozkurt O, de Boer A, Grobbee DE, et al. Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics. Am J Hypertens 2009, 22: 545-51.
34. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest 1995, 96: 2975-9.
35. Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000, 36: 411-6.
36. Hilgers KF, Langenfeld MR, Schlaich M, Veelken R, Schmieder RE. 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation 1999, 100: 1394-9. (Pubitemid 29451698)
37. Frojdo S, Sjolind L, Parkkonen M, et al; FinnDiane Study Group. Polymorphisms in the gene encoding angiotensin i converting enzyme 2 and diabetic nephropathy. Diabetologia 2005, 48: 2278-81. (Pubitemid 41618918)
38. Benjafield AV, Wang WY, Morris BJ. No association of angiotensin- converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens 2004, 17: 624-8. (Pubitemid 38844990)
39. Niu W, Qi Y, Hou S, Zhou W, Qiu C. Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in han chinese. Transl Res 2007, 150: 374-80. (Pubitemid 350101437)
40. Wysocki J, Ye M, Soler MJ, et al. ACE and ACE2 activity in diabetic mice. Diabetes 2006, 55: 2132-9. (Pubitemid 44509989)